A candidate panel of eight urinary proteins shows potential of early diagnosis and risk assessment for diabetic kidney disease in type 1 diabetes
Journal of Proteomics · 2024-05 · 300 · 105167
DOI: 10.1016/j.jprot.2024.105167 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteomics, 2024-05. Verfasst von Jeremy Altman und 9 weiteren Autor:innen. Beteiligte Einrichtung: Center for Biotechnology and Genomic Medicine, Augusta University, Augusta, GA 30912, USA. Electronic address: jaltman@augusta.edu. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Diabetes Mellitus, Type 1, Biomarkers, Early Diagnosis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 59 Literaturangaben.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Diabetic kidney disease (DKD) poses a significant health challenge for individuals with diabetes. At its initial stages, DKD often presents asymptomatically, and the standard for non-invasive diagnosis, the albumin-creatinine ratio (ACR), employs discrete categorizations (normal, microalbuminuria, macroalbuminuria) with limitations in sensitivity and specificity across diverse population cohorts. Single biomarker reliance further restricts the predictive value in clinical settings. Given the escalating prevalence of diabetes, our study uses proteomic technologies to identify novel urinary proteins as supplementary DKD biomarkers. A total of 158 T1D subjects provided urine samples, with 28 (15 DKD; 13 non-DKD) used in the discovery stage and 131 (45 DKD; 40 pDKD; 46 non-DKD) used in the confirmation. We identified eight proteins (A1BG, AMBP, AZGP1, BTD, RBP4, ORM2, GM2A, and PGCP), all of which demonstrated excellent area-under-the-curve (AUC) values (0.959 to 0.995) in distinguishing DKD from non-DKD. Furthermore, this multi-marker panel successfully segregated the most ambiguous group (microalbuminuria) into three distinct clusters, with 80% of subjects aligning either as DKD or non-DKD. The remaining 20% exhibited continued uncertainty. Overall, the use of these candidate urinary proteins allowed for the better classification of DKD and offered potential for significant improvements in the early identification of DKD in T1D populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Biotechnology and Genomic Medicine, Augusta University, Augusta, GA 30912, USA. Electronic address: jaltman@augusta.edu.
- Center for Biotechnology and Genomic Medicine, Augusta University, Augusta, GA 30912, USA. Electronic address: sbai@augusta.edu.
- Center for Biotechnology and Genomic Medicine, Augusta University, Augusta, GA 30912, USA; Department of Obstetrics and Gynecology, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA. Electronic addr…
- Department of Medicine, Medical College of Georgia, Augusta University, Augusta, GA 30912, USA. Electronic address: jowhite@augusta.edu.
- Southeastern Endocrine and Diabetes, Atlanta, GA 30076, USA.
- Department of Endocrinology, Jiangsu Provincial Hospital of Traditional Chinese Medicine, Nanjing, Jiangsu Province.
Zitieren
APA
Altman, J., Bai, S., Purohit, S., White, J., Steed, D., Liu, S., Hopkins, D., She, J. X., Sharma, A., & Zhi, W. (2024). A candidate panel of eight urinary proteins shows potential of early diagnosis and risk assessment for diabetic kidney disease in type 1 diabetes. Journal of Proteomics, 300, 105167. https://doi.org/10.1016/j.jprot.2024.105167
Vancouver
Altman J, Bai S, Purohit S, White J, Steed D, Liu S, et al. A candidate panel of eight urinary proteins shows potential of early diagnosis and risk assessment for diabetic kidney disease in type 1 diabetes. Journal of Proteomics. 2024;300:105167. doi:10.1016/j.jprot.2024.105167
BibTeX
@article{Altman2024,
author = {Altman, Jeremy and Bai, Shan and Purohit, Sharad and White, John and Steed, Dennis and Liu, Su and Hopkins, Diane and She, Jin-Xiong and Sharma, Ashok and Zhi, Wenbo},
title = {A candidate panel of eight urinary proteins shows potential of early diagnosis and risk assessment for diabetic kidney disease in type 1 diabetes},
journal = {Journal of Proteomics},
year = {2024},
volume = {300},
pages = {105167},
doi = {10.1016/j.jprot.2024.105167}
}
EUVIMED